Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Nivolumab + Doxorubicin, Vinblastine, and Dacarbazine in HIV-Associated Advanced-Stage Classic Hodgkin Lymphoma.
Journal: JCO oncology advances
Published: August 11, 2026
Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826).
Journal: Blood advances
Published: June 10, 2026
Classic Hodgkin Lymphoma in the Older Adult: What's New?
Journal: Hematology/oncology clinics of North America
Published: February 18, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 09, 2026
American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.
Journal: Transplantation and cellular therapy
Published: December 09, 2025
Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Prognostic discussions in patients with advanced lymphoma: Characteristics and challenges.
Journal: Palliative & supportive care
Published: September 12, 2025
Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop.
Journal: Blood advances
Published: August 27, 2025
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop.
Journal: Blood advances
Published: August 27, 2025
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell Lymphoma.
Journal: Blood advances
Published: July 14, 2025
Last Updated: 09/26/2026